nach oben

Erschienen in:

01.11.2011 | Original Article

Identifying tumor patients' depression

verfasst von: Susanne Singer, Anna Brown, Jens Einenkel, Johann Hauss, Andreas Hinz, Andrea Klein, Kirsten Papsdorf, Jens-Uwe Stolzenburg, Elmar Brähler

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare the precision of two different methods in detecting clinical depression in tumor patients: the use of a screening questionnaire versus the assessment by health care providers (nurses and doctors).

Methods

During their first days of inpatient cancer treatment, tumor patients were interviewed using the Structured Clinical Interview for DSM (SCID). Their physicians and nurses were asked to assess the mental health of the patients and their need for professional psychosocial support. Additionally, every patient completed the Hospital Anxiety and Depression Scale (HADS).

Results

Out of 329 patients, 28 were diagnosed with either a major or a minor depression according to the SCID. Physicians assessed 15 of the depressed patients as being depressed (sensitivity, 0.54; specificity, 0.38). Nurses identified 19 (sensitivity, 0.68; specificity, 0.45) and the HADS 27 (sensitivity, 0.96; specificity, 0.50) of the depressed patients.

Conclusion

The HADS performed well in detecting depressed cancer patients in acute oncological care, whereas physicians and nurses often were unable to recognize depressed patients.

Surbone A, Baider L, Weitzman TS, Brames MJ, Rittenberg CN, Johnson J (2009) Psychosocial care for patients and their families is integral to supportive care in cancer: MASCC position statement. Support Care Cancer. doi:10.1007/s00520-009-0693-4 PubMed

Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N (2004) Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer 12:161–167PubMedCrossRef

Kelly BJ, Pelusi D, Burnett PC, Varghese FT (2004) The prevalence of psychiatric disorder and the wish to hasten death among terminally ill cancer patients. Palliat Support Care 2:163–169PubMedCrossRef

Gil Moncayo FL, Costa RG, Perez FJ, Salamero M, Sanchez N, Sirgo A (2008) Adaptación psicológica y prevalencia de trastornos mentales en pacientes con cáncer. Med Clín 130:90–92CrossRef

Härter M, Reuter K, Schretzmann B, Hasenburg A, Aschenbrenner A, Weis J (2000) Komorbide psychische Störungen bei Krebspatienten in der stationären Akutbehandlung und medizinischen Rehabilitation. Rehabilitation 39:317–323PubMedCrossRef

Iqbal A (2004) Common types of mental disorders in adult cancer patients seen at Shaukat Khanum Memorial Cancer Hospital and Research Centre. JAMC 16:65–69PubMed

Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C (2006) Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Depress Anxiety 23:441–448PubMedCrossRef

Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, Maguire P, House A, Ramirez A, Cull A (2004) Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 90:314–320PubMedCrossRef

Wancata J, Benda N, Windhaber J, Nowotny M (2001) Does psychiatric comorbidity increase the length of stay in general hospitals? Gen Hosp Psychiatry 23:8–14PubMedCrossRef

10.

Utne I, Miaskowski C, Bjordal K, Paul SM, Rustoen T (2010) The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic. J Palliat Med 13:311–318PubMedCrossRef

11.

Antypa N, Van der Does AJW, Penninx BWJH (2010) Cognitive reactivity: investigation of a potentially treatable marker of suicide risk in depression. J Affect Disord 122:46–52PubMedCrossRef

12.

Akechi T, Okamura H, Kugaya A, Nakano T, Nakanishi T, Akizuki N, Yamawaki S, Uchitomi Y (2000) Suicidal ideation in cancer patients with major depression. Jpn J Clin Oncol 30:221–224PubMedCrossRef

13.

Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE (2010) The interpersonal theory of suicide. Psychol Rev 117:575–600PubMedCrossRef

14.

Davidson CL, Wingate LR, Rasmussen KA, Slish ML (2009) Hope as a predictor of interpersonal suicide risk. Suicide Life-Threat Behav 39:499–507PubMedCrossRef

15.

Sanatani M, Schreier G, Stitt L (2008) Level and direction of hope in cancer patients: an exploratory longitudinal study. Support Care Cancer 16:493–499PubMedCrossRef

16.

Krauß O, Ernst J, Kuchenbecker D, Hinz A, Schwarz R (2007) Prädiktoren psychischer Störungen bei Tumorpatienten: Empirische Befunde. PPmP 57:273–280PubMed

17.

Price A, Hotopf M (2009) The treatment of depression in patients with advanced cancer undergoing palliative care. Curr Opin Support Palliat Care 3:61–66PubMedCrossRef

18.

Naaman SC, Radwan K, Fergusson D, Johnson S (2009) Status of psychological trials in breast cancer patients: a report of three meta-analyses. Psychiatry 72:50–69PubMedCrossRef

19.

Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15:123–136PubMedCrossRef

20.

Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA (2008) Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev (2):CD005537

21.

Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S (2001) How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 84:179–185PubMedCrossRef

22.

Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015PubMedCrossRef

23.

Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A (1998) How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 83:1640–1651PubMedCrossRef

24.

Keller M, Sommerfeldt S, Fischer C, Knight L, Riesbeck M, Lowe B, Herfarth C, Lehnert T (2004) Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol 15:1243–1249PubMedCrossRef

25.

First M, Spitzer R, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV Axis I disorders (SCID-I), clinician version. American Psychiatric Press, Washington

26.

Wittchen H-U, Zaudig M, Fydrich T (1997) SKID-Strukturiertes Klinisches Interview für DSM-IV. Hogrefe-Verlag, Göttingen

27.

Segal DL, Hersen M, Van Hasselt VB (1994) Reliability of the structured clinical interview for DSM-III-R: an evaluative review. Compr Psychiatry 35:316–327PubMedCrossRef

28.

Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

29.

Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebmann A, Krauß O, Lehmann A, Schwarz R (2009) Hospital Anxiety and Depression Scale cut-off scores for cancer patients in acute care. Br J Cancer 100:908–912PubMedCrossRef

30.

Herrmann C, Buss U, Snaith RP (1995) HADS-D: Hospital Anxiety and Depression Scale. Huber, Bern (Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin [Deutsche version])

31.

StataCorp (2007) Stata Statistical Software: release 10. StataCorp LP, College Station

32.

Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S (1998) Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 16:1594–1600PubMed

33.

Pitceathly C, Maguire P, Fletcher I, Parle M, Tomenson B, Creed F (2009) Can a brief psychological intervention prevent anxiety or depressive disorders in cancer patients? A randomised controlled trial. Ann Oncol 20:928–934PubMedCrossRef

34.

Classen CC, Kraemer HC, Blasey C, Giese-Davis J, Koopman C, Palesh OG, Atkinson A, Dimiceli S, Stonisch-Riggs G, Westendorp J, Morrow GR, Spiegel D (2008) Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology 17:438–447PubMedCrossRef

35.

Mitchell AJ, Kaar S, Coggan C, Herdman J (2008) Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology 17:226–236PubMedCrossRef

36.

Jones LE, Doebbeling CC (2007) Suboptimal depression screening following cancer diagnosis. Gen Hosp Psychiatry 29:547–554PubMedCrossRef

37.

Alexandrowicz R, Weiss M, Marquart B, Wancata J (2008) The validity of a two-step-screening procedure for depression. Psychiatr Prax 35:294–301PubMedCrossRef

38.

Passik SD, Donaghy KB, Theobald DE, Lundberg JC, Holtsclaw E, Dugan J (2000) Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program. J Pain Symptom Manage 19:329–338PubMedCrossRef

39.

Fallowfield L, Lipkin M, Hall A (1998) Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. J Clin Oncol 16:1961–1968PubMed

Titel: Identifying tumor patients' depression
verfasst von: Susanne Singer
Anna Brown
Jens Einenkel
Johann Hauss
Andreas Hinz
Andrea Klein
Kirsten Papsdorf
Jens-Uwe Stolzenburg
Elmar Brähler
Publikationsdatum: 01.11.2011
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 11/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-1004-9

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Identifying tumor patients' depression